243 related articles for article (PubMed ID: 1658748)
1. Local base sequence preferences for DNA cleavage by mammalian topoisomerase II in the presence of amsacrine or teniposide.
Pommier Y; Capranico G; Orr A; Kohn KW
Nucleic Acids Res; 1991 Nov; 19(21):5973-80. PubMed ID: 1658748
[TBL] [Abstract][Full Text] [Related]
2. Distribution of topoisomerase II cleavage sites in simian virus 40 DNA and the effects of drugs.
Pommier Y; Capranico G; Orr A; Kohn KW
J Mol Biol; 1991 Dec; 222(4):909-24. PubMed ID: 1662289
[TBL] [Abstract][Full Text] [Related]
3. Similar sequence specificity of mitoxantrone and VM-26 stimulation of in vitro DNA cleavage by mammalian DNA topoisomerase II.
Capranico G; De Isabella P; Tinelli S; Bigioni M; Zunino F
Biochemistry; 1993 Mar; 32(12):3038-46. PubMed ID: 8384486
[TBL] [Abstract][Full Text] [Related]
4. Effects of base mutations on topoisomerase II DNA cleavage stimulated by mAMSA in short DNA oligomers.
Capranico G; Tinelli S; Zunino F; Kohn KW; Pommier Y
Biochemistry; 1993 Jan; 32(1):145-52. PubMed ID: 8380330
[TBL] [Abstract][Full Text] [Related]
5. Drug-specific sites of topoisomerase II DNA cleavage in Drosophila chromatin: heterogeneous localization and reversibility.
Borgnetto ME; Zunino F; Tinelli S; Kas E; Capranico G
Cancer Res; 1996 Apr; 56(8):1855-62. PubMed ID: 8620504
[TBL] [Abstract][Full Text] [Related]
6. Analysis of eukaryotic topoisomerase II cleavage sites in the presence of the quinolone CP-115,953 reveals drug-dependent and -independent recognition elements.
Spitzner JR; Chung IK; Gootz TD; McGuirk PR; Muller MT
Mol Pharmacol; 1995 Aug; 48(2):238-49. PubMed ID: 7651357
[TBL] [Abstract][Full Text] [Related]
7. Mammalian topoisomerase II activity is modulated by the DNA minor groove binder distamycin in simian virus 40 DNA.
Fesen M; Pommier Y
J Biol Chem; 1989 Jul; 264(19):11354-9. PubMed ID: 2544590
[TBL] [Abstract][Full Text] [Related]
8. Local sequence requirements for DNA cleavage by mammalian topoisomerase II in the presence of doxorubicin.
Capranico G; Kohn KW; Pommier Y
Nucleic Acids Res; 1990 Nov; 18(22):6611-9. PubMed ID: 2174543
[TBL] [Abstract][Full Text] [Related]
9. Position-specific effects of base mismatch on mammalian topoisomerase II DNA cleaving activity.
Bigioni M; Zunino F; Tinelli S; Austin CA; Willmore E; Capranico G
Biochemistry; 1996 Jan; 35(1):153-9. PubMed ID: 8555169
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of amsacrine and epipodophyllotoxins on topoisomerase II cleavage in the human c-myc protooncogene.
Pommier Y; Orr A; Kohn KW; Riou JF
Cancer Res; 1992 Jun; 52(11):3125-30. PubMed ID: 1317259
[TBL] [Abstract][Full Text] [Related]
11. DNA sequence preferences at sites cleaved by human DNA topoisomerase II in response to novel quinolone derivatives.
Huff AC; Robinson RG; Evans AC; Selander KN; Wentland MP; Rake JB; Coughlin SA
Anticancer Drug Des; 1995 Apr; 10(3):251-76. PubMed ID: 7748459
[TBL] [Abstract][Full Text] [Related]
12. In vivo mapping of DNA topoisomerase II-specific cleavage sites on SV40 chromatin.
Yang L; Rowe TC; Nelson EM; Liu LF
Cell; 1985 May; 41(1):127-32. PubMed ID: 2986841
[TBL] [Abstract][Full Text] [Related]
13. Topological complexes between DNA and topoisomerase II and effects of polyamines.
Pommier Y; Kerrigan D; Kohn K
Biochemistry; 1989 Feb; 28(3):995-1002. PubMed ID: 2540827
[TBL] [Abstract][Full Text] [Related]
14. Sequence-selective topoisomerase II inhibition by anthracycline derivatives in SV40 DNA: relationship with DNA binding affinity and cytotoxicity.
Capranico G; Zunino F; Kohn KW; Pommier Y
Biochemistry; 1990 Jan; 29(2):562-9. PubMed ID: 2154250
[TBL] [Abstract][Full Text] [Related]
15. Topoisomerase-II-mediated lesions in nascent DNA: comparison of the effects of epipodophyllotoxin derivatives, VM-26 and VP-16, and 9-anilinoacridine derivatives, m-AMSA and o-AMSA.
Woynarowski JM; Sigmund RD; Beerman TA
Biochim Biophys Acta; 1988 May; 950(1):21-9. PubMed ID: 2833925
[TBL] [Abstract][Full Text] [Related]
16. Topoisomerase II as a target of VM-26 and 4'-(9-acridinylamino)methanesulfon-m-aniside in atypical multidrug resistant human small cell lung carcinoma cells.
de Jong S; Kooistra AJ; de Vries EG; Mulder NH; Zijlstra JG
Cancer Res; 1993 Mar; 53(5):1064-71. PubMed ID: 8382551
[TBL] [Abstract][Full Text] [Related]
17. An antitumor drug-induced topoisomerase cleavage complex blocks a bacteriophage T4 replication fork in vivo.
Hong G; Kreuzer KN
Mol Cell Biol; 2000 Jan; 20(2):594-603. PubMed ID: 10611238
[TBL] [Abstract][Full Text] [Related]
18. DNA topoisomerases I & II cleavage sites in the type 1 human immunodeficiency virus (HIV-1) DNA promoter region.
Pommier Y; Poddevin B; Gupta M; Jenkins J
Biochem Biophys Res Commun; 1994 Dec; 205(3):1601-9. PubMed ID: 7811242
[TBL] [Abstract][Full Text] [Related]
19. Application of a degenerate consensus sequence to quantify recognition sites by vertebrate DNA topoisomerase II.
Spitzner JR; Muller MT
J Mol Recognit; 1989 Sep; 2(2):63-74. PubMed ID: 2561527
[TBL] [Abstract][Full Text] [Related]
20. A unique type II topoisomerase mutant that is hypersensitive to a broad range of cleavage-inducing antitumor agents.
O'Reilly EK; Kreuzer KN
Biochemistry; 2002 Jun; 41(25):7989-97. PubMed ID: 12069589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
